Lineage Cell Therapeutics (LCTX) Amortizatization of Intangibles (2010 - 2024)
Lineage Cell Therapeutics (LCTX) reported Amortizatization of Intangibles of $22000.0 for Q1 2024, down 33.33% on a YoY basis from $33000.0 in Q2 2023, and down 31.25% quarter-over-quarter from $32000.0 in Q4 2023.
Lineage Cell Therapeutics (LCTX) Amortizatization of Intangibles (2010 - 2024) Analysis & Trends
Lineage Cell Therapeutics has reported Amortizatization of Intangibles for 15 years, with the latest figure at $22000.0 in Q1 2024.
- For the quarter ending Q1 2024, Amortizatization of Intangibles fell 33.33% year-over-year to $22000.0; the trailing twelve-month figure through Dec 2024 stood at $22000.0 (down 83.08% YoY), and the FY2024 full-year result was $22000.0, down 83.08% from the prior year.
- Amortizatization of Intangibles for Q1 2024 stood at $22000.0, down from $32000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $498000.0 in Q1 2020, with the low at -$1.0 million in Q4 2020.
- Historically, Amortizatization of Intangibles has averaged $31117.6 across 5 years, with a median of $33000.0 in 2021.
- The largest YoY upside for Amortizatization of Intangibles was 3457.14% in 2020 against a maximum downside of 302.41% in 2020.
- Lineage Cell Therapeutics' Amortizatization of Intangibles stood at -$1.0 million in 2020, then jumped by 103.17% to $32000.0 in 2021, then tumbled by 140.62% to -$13000.0 in 2022, then jumped by 346.15% to $32000.0 in 2023, then plunged by 31.25% to $22000.0 in 2024.
- The last three Amortizatization of Intangibles figures came in at $22000.0 (Q1 2024), $32000.0 (Q4 2023), and $33000.0 (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Lineage Cell Therapeutics | 303.84 Mn | 239.94 Mn | 1.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 22,000.00 |
| Mar 31, 2024 | 22,000.00 |
| Dec 31, 2023 | 32,000.00 |
| Dec 31, 2023 | 32,000.00 |
| Sep 30, 2023 | 33,000.00 |
| Sep 30, 2023 | 33,000.00 |
| Jun 30, 2023 | 32,000.00 |
| Jun 30, 2023 | 32,000.00 |
| Mar 31, 2023 | 33,000.00 |
| Mar 31, 2023 | 33,000.00 |
| Dec 31, 2022 | -13,000.00 |
| Dec 31, 2022 | -13,000.00 |
| Sep 30, 2022 | 48,000.00 |
| Sep 30, 2022 | 48,000.00 |
| Jun 30, 2022 | 32,000.00 |
| Jun 30, 2022 | 32,000.00 |
| Mar 31, 2022 | 28,000.00 |
| Mar 31, 2022 | 28,000.00 |
| Dec 31, 2021 | 32,000.00 |
| Dec 31, 2021 | 32,000.00 |